Michael E. Menefee
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 8
- Oncology 7
- Cancer-related Molecular Pathways 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Tito Fojo (2 shared papers)Antonio Tito Fojo (1 shared paper)Keith Christopher Bible (8 shared papers)Robert C. Smallridge (6 shared papers)Charles Erlichman (6 shared papers)Jill K. Burton (3 shared papers)Kevin P. Webster (2 shared papers)Vera Jean Suman (2 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (4 papers)Clinical Cancer Research (3 papers)Investigational New Drugs (3 papers)American Society of Clinical Oncology Educational Book (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesSingaporeCanada
In The Last Decade
Michael E. Menefee
28 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 80
- Endocrinology, Diabetes and Metabolism 683
- Oncology 562
- Cancer Research 134
- Molecular Biology 457
- Cell Biology 106
Countries citing papers authored by Michael E. Menefee
This map shows the geographic impact of Michael E. Menefee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Menefee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Menefee more than expected).
Fields of papers citing papers by Michael E. Menefee
This network shows the impact of papers produced by Michael E. Menefee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Menefee. The network helps show where Michael E. Menefee may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Menefee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 359 | |
| 2 | 2007 | 192 | |
| 3 | 2012 | 146 | |
| 4 | 2017 | 105 | |
| 5 | 2005 | 104 | |
| 6 | 2013 | 97 | |
| 7 | 2014 | 95 | |
| 8 | 2014 | 58 | |
| 9 | 2012 | 54 | |
| 10 | 2017 | 50 | |
| 11 | 2010 | 35 | |
| 12 | 2009 | 33 | |
| 13 | 2019 | 25 | |
| 14 | 2020 | 23 | |
| 15 | 2010 | 23 | |
| 16 | 2013 | 16 | |
| 17 | 2020 | 14 | |
| 18 | 2012 | 10 | |
| 19 | Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma. | 2013 | 6 |
| 20 | 2023 | 4 |
About Michael E. Menefee
Michael E. Menefee is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Ecological Modeling, Cell Biology and Genetics, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (8 papers), Cancer-related Molecular Pathways (3 papers), Species Distribution and Climate Change (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer Treatment and Pharmacology (2 papers), Renal cell carcinoma treatment (2 papers), Melanoma and MAPK Pathways (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (683 citations), Oncology (562 citations), Cancer Research (134 citations), Molecular Biology (457 citations) and Cell Biology (106 citations). Michael E. Menefee has collaborated with scholars based in United States, Singapore and Canada. Frequent co-authors include Tito Fojo, Antonio Tito Fojo, Keith Christopher Bible, Robert C. Smallridge, Charles Erlichman, Jill K. Burton, Kevin P. Webster, Vera Jean Suman, Julian R. Molina and Anne M. Traynor. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Cancer Research, Investigational New Drugs, American Society of Clinical Oncology Educational Book and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.